NDC 0061-6607-05 - Arovyn
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0061-6607
- Requested NDC
- 0061-6607-05
- Package NDCs from labels
- 0061-6607-02, 0061-6607-03, 0061-6607-04, 0061-6607-05
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2024-10-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AROVYN™ (tulathromycin injection) | Merck Sharp & Dohme Corp. | 2024-10-28 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0061-6607-02 | Arovyn | 50 mL in 1 VIAL, GLASS | INJECTION | 50 | 4 | |
| 0061-6607-03 | Arovyn | 100 mL in 1 VIAL, GLASS | INJECTION | 100 | 4 | |
| 0061-6607-04 | Arovyn | 250 mL in 1 VIAL, GLASS | INJECTION | 250 | 4 | |
| 0061-6607-05 | Arovyn | 500 mL in 1 VIAL, GLASS | INJECTION | 500 | 4 |
DailyMed Dashboard NDC Coverage#
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.